Mazen Juratli- Medicine- Outstanding Scientist Award

Posted on by Leave a Comment on Mazen Juratli- Medicine- Outstanding Scientist Award

Mazen Juratli- Medicine- Outstanding Scientist Award

Prof. Mazen Juratli distinguished academic and researcher in the field Medicine. He is a dedicated and accomplished Assistant Professor and Senior Consultant Surgeon with a strong background in General, Visceral, and Transplant Surgery, specializing in upper GI tumors, reflux surgery, and peritoneal carcinomatosis. His experience encompasses both the clinical and research facets of surgical oncology, demonstrating a steadfast dedication to advancing medical science and enhancing patient care. He is actively pursuing opportunities to make substantial contributions to the field of surgery and academic medicine, particularly in the realm of Upper GI and peritoneal carcinomatosis surgery, along with related areas.

🌐 Professional Profile

Educations📚📚📚

He earned his Ph.D. in Interdisciplinary Biomedical Science (IBS) from the Arkansas Nanomedicine Center at the University of Arkansas for Medical Sciences (UAMS) in Little Rock, AR, USA, completing his studies between January 2012 and May 2014. Prior to that, he attended medical school at Philipps University in Marburg, Germany, from October 2003 to November 2009.

 Experience:

He is currently an Assistant Professor and Senior Consultant Surgeon at the University Hospital of Muenster in Muenster, Germany, within the Department of Generalhttps://networkscience-conferences.researchw.com/?p=33910&preview=true, Visceral, and Transplant Surgery. He specializes as an Upper Gastrointestinal (GI) Surgeon, adept in robotic, minimally invasive, and open surgeries. Additionally, he heads the Stomach Cancer and Peritoneal Carcinomatosis Surgical Center, serves as Deputy Head of the Esophagus Cancer Center, and leads the Surgical Biobank. He is also the Principal Investigator (PI) for the Liquid Biopsy Research Group. His licensure and certifications include being a Senior Explant Surgeon for Donor Surgery: Liver and Kidney (since October 2023) and a Certified Center Surgeon for the Upper GI Tract (since January 2023). He is a member of the Board of Directors of the Interdisciplinary Working Group for Clinical Hemotherapy (IAKH e.V.) and holds an additional qualification in Specialized Visceral Surgery (Zusatzbezeichnung Spezielle Viszeralchirurgie) from the Ärztekammer Westfalen-Lippe, Germany, since September 2022. He became a Fellow of the European Board of Surgery (F.E.B.S.) in Surgical Oncology in September 2022 and has been an Assistant Professor (Privatdozent Dr. med. habil.) since January 2021. He has served as a Senior Consultant Surgeon (Oberarzt) in the Department of General, Visceral, and Transplant Surgery at the University Hospital of Muenster since September 2020. He obtained his German Board Certification in Visceral Surgery – Consultant Surgeon (Facharzt) from the Ärztekammer Hessen, Germany, in June 2019. He earned his Ph.D. from the University of Arkansas for Medical Sciences (UAMS) in Little Rock, AR, USA, in December 2014 and his Doctor of Medicine (Dr. med.) from Philipps University in Marburg, Germany, in December 2009, where he also obtained his German Federal License (Approbation) in November 2009.

Awards, Grants and Honors

He has received numerous awards, grants, and honors throughout his career. In 2024, he secured industrial grant funding from Johnson & Johnson for a project on surgical smoke exposure investigation in surgical safety, amounting to €169,681, and also received the German Society for General and Visceral Surgery (DGAV) Travel Award, valued at €5000. He earned abstract prizes for his pilot studies on diagnostic and prognostic tumor markers in adenocarcinomas of the gastroesophageal junction and extracellular vesicles as potential biomarkers for hepatocellular carcinoma, presented at Visceral Medicine 2023 in Hamburg and NRW-Visceral Medicine 2023 in Essen, each prize valued at €500. In 2022, he won another abstract prize for his work on the long-term effects of liver resection on circulating stem cells in hepatocellular carcinoma, presented at Visceral Medicine in Hamburg. He was recognized as a Medical Scientist by the Else Kröner-Forschungskolleg (EKFK) in 2018 and received a grant of €15,000 from the B. Braun-Stiftung the same year. In 2017, he was awarded €66,000 for young talent promotion by Frankfurt Research Promotion at Goethe University, Frankfurt am Main, Germany. His achievements also include the Frankfurt Research Prize of the Rudolf Geißendörfer Foundation in 2015, valued at €5,000, and a poster prize at the 19 Chirurgische Forschungstage in Würzburg, Germany, in 2015, valued at €500. He received the second prize for the Cancers Best Paper Award in 2015 and the German Academic International Network (GAIN) Travel Award to attend the 18th European Career Fair (ECF) in Boston, MA, USA, in 2014, valued at €2,000. He was honored with the People’s Choice award for Science as Art at the Nanotechnology for Health Care Conference in Petit Jean, AR, USA, in 2014. Additionally, he was granted $78,000 by the Arkansas Breast Cancer Research Program (ABCRP) in 2013 and received €50,000 from the DFG – German Research Foundation in 2012.

 

📝🔬Publications📝🔬

  • Jens Hoelzen, Lukas Fortmann, Dhruvajyoti Roy, Carsten Szardenings, Martina Holstein, Ann-Kathrin Eichelmann,Emile Rijcken,Brooke E. Frankauer, Peter Barth, Eva Wardelmann, Andreas Pascher, and Mazen A. Juratli. Robotic-Assisted Esophagectomy with Total Mesoesophageal Excision EnhancesR0-Resection in Patients with Esophageal Cancer – a single-center experience. Surgery 05/2024. In Press
  • Lamberty SA, Hoelzen JP, Katou S, Becker F, Juratli MA, Andreou A, Morgül MH, Pascher A, Strücker B. Validation of the IWATE Criteria in Robotic-Assisted Liver Resections. J Clin Med. 2024 May 3;13(9):2697. doi: 10.3390/jcm13092697. PMID: 38731226; PMCID: PMC11084793.
  • Juratli, M.A., Pollmann, N.S., Oppermann, E. et al. Extracellular vesicles as potential biomarkers for diagnosis and recurrence detection of hepatocellular carcinoma. Sci Rep 14, 5322 (2024). https://doi.org/10.1038/s41598-024-55888-8.
  • Diedrich AM, Daneshgar A, Tang P, Klein O, Mohr A, Onwuegbuchulam OA, von Rueden S, Menck K, Bleckmann A, Juratli MA, Becker F, Sauer IM, Hillebrandt KH, Pascher A, Struecker B. Proteomic analysis of decellularized mice liver and kidney extracellular matrices. J Biol Eng. 2024 Feb 22;18(1):17. doi: 10.1186/s13036-024-00413-8. PMID: 38389090; PMCID: PMC10885605
  • de Jongh C, Cianchi F, Kinoshita T, Kingma F, Piccoli M, Dubecz A, Kouwenhoven E, van Det M, Mala T, Coratti A, Ubiali P, Turner P, Kish P, Borghi F, Immanuel A, Nilsson M, Rouvelas I, Hӧlzen JP, Rouanet P, Saint-Marc O, Dussart D, Patriti A, Bazzocchi F, van Etten B, Haveman JW, DePrizio M, Sabino F, Viola M, Berlth F, Grimminger PP, Roviello F, van Hillegersberg R, Ruurda J; UGIRA Collaborative Group. Surgical Techniques and Related Perioperative Outcomes After Robot-assisted Minimally Invasive Gastrectomy (RAMIG): Results From the Prospective Multicenter International Ugira Gastric Registry. Ann Surg. 2023 Nov 3. doi: 10.1097/SLA.0000000000006147. Epub ahead of print. PMID: 37922237.
  • Hoelzen JP, Frankauer BE, Szardenings C, Roy D, Pollmann L, Fortmann L, Merten J, Rijcken E, Juratli MA, Pascher A. Reducing the Risks of Esophagectomies: A Retrospective Comparison of Hybrid versus Full-Robotic-Assisted Minimally Invasive Esophagectomy (RAMIE) Approaches. J Clin Med. 2023 Sep 7;12(18):5823. doi: 10.3390/jcm12185823. PMID: 37762765; PMCID: PMC10531670.Two senior authors
  • Peters AK, Juratli MA, Roy D, Merten J, Fortmann L, Pascher A, Hoelzen JP. Factors Influencing Postoperative Complications Following Minimally Invasive Ivor Lewis Esophagectomy: A Retrospective Cohort Study. J Clin Med. 2023 Aug 31;12(17):5688. doi: 10.3390/jcm12175688. PMID: 37685756; PMCID: PMC10488704.Contributed equally to the study
  • Mohr A, Besser M, Broichhausen S, Winter M, Bungert AD, Strücker B, Juratli MA,Pascher A, Becker F. The Influence of Apremilast-Induced Macrophage Polarization on Intestinal Wound Healing. J Clin Med. 2023 May 9;12(10):3359. doi: 10.3390/jcm12103359. PMID: 37240465; PMCID: PMC10219563

Susanta Kumar Sahu – Biological Award – Best Researcher Award

Posted on by Leave a Comment on Susanta Kumar Sahu – Biological Award – Best Researcher Award

Susanta Kumar Sahu – Biological Award – Best Researcher Award

Assoc Prof Dr. Susanta Kumar Sahu distinguished academic and researcher in the field Biological. He has been employed at Utkal University since November 2001, where he served as a Reader and Head during various periods: from June 2011 to May 2013, August 2015 to May 2017, and June 2019 to September 2021. Additionally, he worked as a Professor & Unit Head at Asmara College of Health Science (Asmara University), under the government of Africa, from January 2016 to July 2016. His tenure also includes serving as an Assistant Professor at Garyounis University, under the government of Africa in Libya, from 2009 to 2010. Earlier in his career, he held positions as a Lecturer at Krupanidhi College of Pharmacy, Bangalore University, from December 1994 to August 1995, and at the Institute of Pharmacy and Technology, Utkal University, from September 1995 to November 2001. Prior to his academic roles, he worked as a Graduate Apprentice at Boots Pharmaceutical in Sion, Bombay, from 1992 to 1993.

🌐 Professional Profiles

Educations📚📚📚

He pursued his academic journey at Berhampur University, Odisha, completing his B.Pharm. in 1992, followed by an M.Pharm. from Dr. M.G.R. Medical University, Tamil Nadu, in 1995, focusing on Pharmaceutical Chemistry with subjects ranging from Medicinal and Organic Chemistry to Chemistry of Natural Products and Instrumental Chemistry. He then earned his Ph.D. in Pharmaceutical Chemistry from Berhampur University in 1999, under the guidance of Prof. P.K Misro and Prof. P.K Panda, specializing in the synthesis and pharmacological studies of new indole derivative drugs and their congeners. Later, in 2009, he achieved a D.Sc. from the same university, delving into Synthetic Chemistry and Biological Evaluation, with a thesis titled “Synthesis and Biological Evaluation of New Heterocyclic Compounds,” supervised by Prof. P.K Misro and Prof. P.K Panda.

 Work experiences

He has amassed extensive teaching experience across various prestigious institutions and universities. At UDPS, Utkal University, Bhubaneswar, he has been actively involved in teaching B.Pharm, M.Pharm, and Ph.D. courses since November 22, 2001, and has taken on administrative responsibilities as the Head of the Department during multiple periods, including from June 1, 2011, to May 30, 2013, August 10, 2015, to May 31, 2017, and June 1, 2019, to September 15, 2021. His teaching duties have encompassed Medicinal Chemistry, Organic Chemistry, Chemistry of Natural Products, and Instrumental Chemistry. Similarly, at Asmara University, Asmara, under the government of Africa, he served as a teacher and researcher, as well as a Unit Head in 2016, contributing to the education of students in B.Pharm and M.Pharm programs. He also taught and conducted research at Garyounis University, Libya, under the government of Africa, from 2009 to 2010, focusing on the same subjects. Earlier in his career, he engaged in teaching and research roles at various institutions, including UDPS, Utkal University, Institute of Pharmacy and Technology in Cuttack under Utkal University, and Krupanidhi College of Pharmacy under Bangalore University, from 1994 to 1995 and 1995 to 2001, respectively. Throughout these positions, he has demonstrated a strong commitment to education and research in the fields of Medicinal Chemistry, Organic Chemistry, Chemistry of Natural Products, and Instrumental Chemistry.

PROFESSIONAL ACTIVITIES AND SERVICE

  Organized Seminar

  • Seminar on Wholeness and Implicate Order, held at MKCG Auditorium, Utkal University Dt. 08 February 2009. (Convenor)
  • National Seminar, School of Pharmacy, Utkal University, Dt. 23-24th March 2002.(asst secretary organizing committee)

As Chairperson

  • Eastern Regional of Indian Pharmacological Society & 21st Annual Conference of Odisha State Brach of IPS, held at SCB Medical College, Cuttack, Dt. 11-13 November 2011.
  • ICMR Sponsored national Seminar on Quality control and Standardization of Ethnopharmaceuticals in the present era organized by Centurion University of Technology and Management, Bhubaneswar on 4-5th March 2018. (as Chairman, Scientific Committee)

Invited Speaker

  • State Level Seminar, IMT Pharmacy College, Puri Dt. 5th April 2013.
  • State Level Seminar, CPS, Puri
  • State Level Seminar, Dadhichi College of PharmacyBBSR
  • J.B. Autonomous College,BBSR
  • School of Pharmacy Centurion University,BBSR
  • GRY College of Pharmacy ,M.P

 

Workshop:

  • Participated as a trainee in the National workshop on Drug design and Discovery at Institute of life sciences from 03-6th march 2014 Bhubaneswar.
  • Participated as Delegate in the workshop on computational tools for protein modeling and lead optimization in drug discovery from 7-8th mar 2014 JSS College of pharmacy Ooty.
  • Working Pharmacist, Institute of Pharmacy & Technology Dt. 27-28th March 2000.

 

Refresher Courses/ Training Programmes/Workshops attended:

  • Attended introduction training program for teachers in Pharmaceutical Sciences sponsored by AICTE from 09thSep-28thSep 1998 at Kakatiya University, Warangal, AP.

Attended UGC sponsored course from 10thJun-30thJun 2002 at Annamali University, Tamil Nadu.

 

📝🔬Publications📝🔬

1.A Combined approach of Pharmacophore modelling, QSAR study ,molecular docking and in Silico ADME/TOX prediction of 4- Arylthioand 4-Arloxy-3-Iodopyridine-2(1H) one analogs to identify potential Reverse Transcriptase inhibitor; anti-HIV agents. Medicinal chemistry.DOI;102174/1573406417666201214100822.(IMF.3.02)

2.Identification of antimycobacterial agent using  insilico virtual  screening ,ADME predication,Docking and Molecular Dynamics simulation approach,  current computer aided Drug Design, 2020 BMS-CCADD-2020-25.DOI:10.2174/1573409916999200730182308  ( IMF.1.66)3. Rational in silico drug design of HIV-RTinhibitors through G-QSAR and moleculardocking study of 4-arylthio and 4-aryloxy-3-iodopyridine-2(1-H)-one derivative. Beni-Suef University Journal of Basic and Applied Sciences

3.Pharmacophore modelling, QSAR study, molecular docking and insilico ADME prediction of1,2,3‑triazole and pyrazolopyridones As DprE1 inhibitor antitubercular agents ,SN Applied Sciences.(IMF.1.0)

4.Computer-aided identification of lead compounds as FtsZ inhibitors using molecular docking, virtual screening, DFT analysis and molecular dynamic simulation, Journal of Molecular Modelling.2019;25;360 http;//doi.org/10.1007/s00894-019-4238-6.(IMF.1.3)

5.FtsZ inhibitors as a new genera of antibacterial agents Review article, Bioorganic Chemistry   doi.org /10.1016/jbioorg.2019. 103169  (IMF.3.9)

6.Pharmacophore generation, atom-based 3D-QSAR, molecular docking and molecular dynamics simulation studies on benzamide

7. analogues as FtsZ inhibitors. Journal of Biomolrcular Structure and Dynamics; 2017, (DOI: 10.1080/07391102.2017.1384401).(IMF.3.02).